Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer

Tumors evade the immune system though a myriad of mechanisms. Using checkpoint inhibitors to help reprime T cells to recognize tumor has had great success in malignancies including melanoma, lung, and renal cell carcinoma. Many tumors including prostate cancer are resistant to such treatment. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Sutherland, Sarah I. M., Ju, Xinsheng, Horvath, L. G., Clark, Georgina J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039370/
https://www.ncbi.nlm.nih.gov/pubmed/33854509
http://dx.doi.org/10.3389/fimmu.2021.641307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039370/
https://www.ncbi.nlm.nih.gov/pubmed/33854509
http://dx.doi.org/10.3389/fimmu.2021.641307

Ejemplares similares